DSCSA is Coming. Are you Ready?
Drug Topics
JULY 18, 2023
The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.
Drug Topics
JULY 18, 2023
The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.
PharmaVoice
JULY 18, 2023
Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 18, 2023
Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.
IDStewardship
JULY 18, 2023
In this article the World Health Organization’s adoption of Firstline as a platform to support antimicrobial stewardship is discussed Interviewee: Jason Buck Interviewer: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 19 July 2023 The battle against antimicrobial resistant microbes is a global one that we are all in together. Over the last few years many antimicrobial stewards from around the world have shared their perspectives and advice here on this blog, weighing in on with
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 18, 2023
Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.
PharmaVoice
JULY 18, 2023
A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 18, 2023
Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.
Drug Topics
JULY 18, 2023
NCPA, NACDS, and APhA have joined the Healthcare Distribution Alliance in calling for a delay in the implementation of DSCSA.
Pharmacy Times
JULY 18, 2023
Pharmacist-led discharge stewardship initiatives have shown promising results.
Drug Topics
JULY 18, 2023
The COVID-19 public health emergency is over. What happens now?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 18, 2023
Though the overall significance of the results were low, vitamin D was found to be especially useful in lowering the prevalence of myocardial infarction in older adults.
Drug Topics
JULY 18, 2023
Device adoption among minority patients with type 1 and type 2 diabetes remains low due to socioeconomic disparities.
Pharmacy Times
JULY 18, 2023
Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.
Drug Topics
JULY 18, 2023
Customers expect high-quality customer service. Technology can help pharmacists meet those expectations.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 18, 2023
Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.
Drug Topics
JULY 18, 2023
Applications which utilize social media appear to reduce smoking relapse rates.
Pharmacy Times
JULY 18, 2023
Neither of the 2 current standards of care offers patients a cure.
Drug Topics
JULY 18, 2023
Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complex condition involving multiple organ systems.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 18, 2023
This months OTC products include brain fuel, SPF 50 mineral sunscreen, women's ensemble, and kids SPF 50 gentle lotion sunscreen.
Drug Topics
JULY 18, 2023
Vonoprazan appeared to be cost saving below a threshold price of $8.57 per pill.
STAT
JULY 18, 2023
Medicaid is an essential source of maternal and postpartum care for low-income Americans, covering 42% of births in the U.S. People who give birth receive maternity care until at least two months after delivery, or longer depending on state or local policies. But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 201
Pharmaceutical Technology
JULY 18, 2023
Scribe Therapeutics and Sanofi have expanded partnership to progress the development of in vivo genetic therapies to treat genomic diseases.
STAT
JULY 18, 2023
In Phoenix, where daytime temperatures are topping 110 degrees Fahrenheit for the third straight week, emergency room doctors think of extreme heat as the public health emergency it has proved itself to be: In 2022, Arizona’s Maricopa County reported a 25% increase in heat-related mortality from the previous year. “Heat is just something we know we need to be really worried about,” said Geoff Comp, an emergency medicine physician at Valleywise Health Medical Center.
Fierce Healthcare
JULY 18, 2023
Teladoc is ramping up its investment in AI to infuse innovation into its telehealth solution for hospitals. | Teladoc is ramping up its investment in AI to infuse innovation into its telehealth solution for hospitals. The largest telehealth company is tapping into its two-year partnership with tech giant Microsoft to integrate AI and speech recognition tech into its Solo virtual care platform.
STAT
JULY 18, 2023
Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies. Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties.
Fierce Healthcare
JULY 18, 2023
Emergency visits and inpatient admissions for conditions related or adjacent to extreme heat events are costing the U.S. | A recent extrapolation of Virginia weather trends and care utilization data suggests that about 234,000 excess emergency department visits and 56,000 hospital admissions occur nationwide due to heat event days.
STAT
JULY 18, 2023
This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.” A RCH Venture Partners, the long-running investment firm that in recent years has dedicated itself to backing biotechs with grandiose plans , also delivered some of the best returns on outside investors’ money, according to the 2023 edition of STAT’s annual ranking of biotech venture capital performance.
The Checkup by Singlecare
JULY 18, 2023
If you’ve been diagnosed with high blood pressure , chances are that you were advised to follow the DASH eating plan. The DASH diet emphasizes eating lots of fruits, veggies, and whole grains while limiting salt, saturated fats, and sweets. The DASH diet is a highly effective meal plan with multiple health benefits for people with hypertension and other related conditions, but starting the plan can feel overwhelming at first.
STAT
JULY 18, 2023
A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle. The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.
STAT
JULY 18, 2023
I’ve heard “WebMD said it could be cancer” countless times in my 15 years working as an emergency medicine physician. I get it: When someone is feeling unwell or hoping a worrying symptom will go away, it makes sense for them to turn to easily accessible resources. As people become increasingly familiar with artificial intelligence platforms like ChatGPT, it’s only a matter of time before patients turn to these tools in search of a diagnosis or second opinion.
Fierce Healthcare
JULY 18, 2023
The Centers for Medicare & Medicaid Services (CMS) could remove PET scan restrictions to better determine whether patients qualify for new drugs and to shine light on whether a drug is slowing | CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline.
STAT
JULY 18, 2023
Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline. The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acti
Let's personalize your content